Combination of Pim kinase inhibitor SGI-1776 and bendamustine in B-cell lymphoma.
about
Mantle cell lymphoma in the era of precision medicine-diagnosis, biomarkers and therapeutic agentsPim-1 kinase as cancer drug target: An updatePIM kinases as potential therapeutic targets in a subset of peripheral T cell lymphoma cases.MicroRNA-mRNA Pairs Associated with Outcome in AML: From In Vitro Cell-Based Studies to AML Patients.PIM-1 contributes to the malignancy of pancreatic cancer and displays diagnostic and prognostic value.Japanese apricot extract (MK615) potentiates bendamustine-induced apoptosis via impairment of the DNA damage response in lymphoma cells.Protein profiling identifies mTOR pathway modulation and cytostatic effects of Pim kinase inhibitor, AZD1208, in acute myeloid leukemia.PIM Kinase as an Executional Target in Cancer
P2860
Q28075606-10BBB624-18C1-4022-9A9F-2CDA09B78360Q28273475-59F1A61B-BE97-4649-BB24-3DF5DD20BE5AQ34489388-3D3AA185-91AB-4032-B89A-29D901960097Q36511384-C3E9EFEB-9126-4755-9131-202E25FEDCA9Q37233255-6345B44D-0881-4699-AB69-F12F07071CEAQ40978733-34CFDAE3-7C4A-44AE-BF0A-1DCB85275778Q42380771-FA184086-50F9-4EFD-B375-077F514466BEQ58128483-828E957B-647A-4B13-A8F3-9D709598754B
P2860
Combination of Pim kinase inhibitor SGI-1776 and bendamustine in B-cell lymphoma.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Combination of Pim kinase inhibitor SGI-1776 and bendamustine in B-cell lymphoma.
@en
type
label
Combination of Pim kinase inhibitor SGI-1776 and bendamustine in B-cell lymphoma.
@en
prefLabel
Combination of Pim kinase inhibitor SGI-1776 and bendamustine in B-cell lymphoma.
@en
P2093
P2860
P1476
Combination of Pim kinase inhibitor SGI-1776 and bendamustine in B-cell lymphoma.
@en
P2093
Lisa S Chen
Qingshan Yang
Sattva S Neelapu
Varsha Gandhi
P2860
P304
P356
10.1016/J.CLML.2013.05.024
P407
P478
13 Suppl 2
P577
2013-09-01T00:00:00Z